OR WAIT 15 SECS
Over the past decade, there have been tremendous improvements in maternal and child healthcare, which has help...
Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery (...
Sciverse Solutions is opening its new headquarters in Pune, where the company develops its diagnostic platform...
BIOCATALYST LEADERSHIP: How Enzymes are Propelling India's Pharma
As silent workhorses of the pharmaceutical industry, enzymes are playing an increasingly important role in shaping how modern medicines are discovered and manufactured. From Active Pharmaceutical Ingredients (API) production and biologics manufacturing to vaccines, biosimilars, and Contract Development and Manufacturing Organisations (CDMO) operations, these biological catalysts are helping drugmakers improve efficiency, sustainability, and product quality. Industry estimates suggest that enzyme-based manufacturing routes can reduce process steps by 20- 50 per cent while improving yields. India is home to more than 100 enzyme companies and a growing biotechnology ecosystem, yet remains heavily dependent on imports for many advanced pharmaceutical biocatalysts. In this story, we examine how enzymes are transforming India's pharmaceutical value chain, the shift towards customised and engineered enzymes, and what it will take for India to emerge as a global hub for enzyme innovation.
For Feedback, please email us at: communications@mmactiv.com
